Search - tctmd.com

Displaying 461 - 480 of 699

Sort: Relevancy | Date

Presentation TCT 2015

Keynote Lecture: If I Had Uncontrolled Hypertension

Presenter: Farrell O. Mendelsohn, William B. White, Horst Sievert

October 11, 2015

Presentation TCT 2015

Recors Trial Program

Presenter: Farrell O. Mendelsohn, William B. White, Laura Mauri

October 11, 2015

Presentation TCT 2015

Update on St. Judes Trial

Presenter: Farrell O. Mendelsohn, William B. White, William A. Gray

October 11, 2015

Presentation TCT 2015

Update on Boston Scientifics REINFORCE

Presenter: Farrell O. Mendelsohn, William B. White, Michael A. Weber

October 11, 2015

Presentation TCT 2015

Update on Medtronics Spyral Global

Presenter: Farrell O. Mendelsohn, William B. White, Michael Böhm

October 11, 2015

Presentation TCT 2015

Considerations and Recommendations for Future Clinical Trials in Device-Based Hypertension Treatments

Presenter: Farrell O. Mendelsohn, William B. White

October 11, 2015

Presentation TCT 2015

Putting It All Together: Procedural Recommendations in 2015

Presenter: Juan F. Granada, Michael Joner, Krishna J. Rocha-Singh

October 11, 2015

Presentation TCT 2015

Influence of Arterial Microanatomy on Response to Renal Artery Catheter Energy Denervation

Presenter: Juan F. Granada, Michael Joner, Elazer R. Edelman

October 11, 2015

Presentation TCT 2015

Time to Revise Treatment Recommendations: Go Distal and Into the Branches

Presenter: Juan F. Granada, Michael Joner, Justin E. Davies

October 11, 2015

Presentation TCT 2015

Lesion Characteristics From the Different Devices: Do They Differ?

Presenter: Juan F. Granada, Michael Joner

October 11, 2015

Presentation TCT 2015

Procedural Parameters for Successful Renal Denervation: Anything on the Horizon?

Presenter: Juan F. Granada, Michael Joner, Michael Böhm

October 11, 2015

Presentation TCT 2015

Nerve Distribution Along the Renal Arteries: From the Branches to the Ostium

Presenter: Juan F. Granada, Michael Joner

October 11, 2015

Presentation TCT 2015

Unresolved Issues and the Path Moving Forward

Presenter: Ajay J. Kirtane, Felix Mahfoud

October 11, 2015

Presentation TCT 2015

Myths as to Why SYMPLICITY HTN-3 Failed

Presenter: Ajay J. Kirtane, Felix Mahfoud, Darrel P. Francis

October 11, 2015

Presentation TCT 2015

Device-Based Therapies for Hypertension Treatment: Procedural Aspects

Presenter: Ajay J. Kirtane, Felix Mahfoud, Farrell O. Mendelsohn

October 11, 2015

Presentation TCT 2015

Uncontrolled Hypertension: Prevalence, Prognosis, and Treatment

Presenter: Ajay J. Kirtane, Felix Mahfoud, Michael A. Weber

October 11, 2015

Presentation

PROTECT-TAVI: AKI With the RenalGuard System in Patients Undergoing TAVR

Presenter: Marco Barbanti

September 21, 2015

Presentation CCVVC 2015

New Concepts in Endovascular Treatment: Present And Future Status Of Renal Denervation After The Negative SIMPLICITY Trial

Presenter: Mark Wholey

June 17, 2015

Presentation TVT 2015

Thoughtful Commentary: Severe Renal Disease and TAVR

Presenter: Howard C. Herrmann, Alec S. Vahanian, E. Murat Tuzcu

June 04, 2015

Presentation

Case Presentation: Severe Renal Disease and TAVR

Presenter: Howard C. Herrmann, Alec S. Vahanian, Philippe Genereux

June 04, 2015

Advertisement

Keynote Lecture: If I Had Uncontrolled Hypertension

Recors Trial Program

Update on St. Judes Trial

Update on Boston Scientifics REINFORCE

Update on Medtronics Spyral Global

Considerations and Recommendations for Future Clinical Trials in Device-Based Hypertension Treatments

Putting It All Together: Procedural Recommendations in 2015

Influence of Arterial Microanatomy on Response to Renal Artery Catheter Energy Denervation

Time to Revise Treatment Recommendations: Go Distal and Into the Branches

Lesion Characteristics From the Different Devices: Do They Differ?

Procedural Parameters for Successful Renal Denervation: Anything on the Horizon?

Nerve Distribution Along the Renal Arteries: From the Branches to the Ostium

Unresolved Issues and the Path Moving Forward

Myths as to Why SYMPLICITY HTN-3 Failed

Device-Based Therapies for Hypertension Treatment: Procedural Aspects

Uncontrolled Hypertension: Prevalence, Prognosis, and Treatment

PROTECT-TAVI: AKI With the RenalGuard System in Patients Undergoing TAVR

New Concepts in Endovascular Treatment: Present And Future Status Of Renal Denervation After The Negative SIMPLICITY Trial

Thoughtful Commentary: Severe Renal Disease and TAVR

Case Presentation: Severe Renal Disease and TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content